Journal: Head and Neck Pathology

Article Title: Primary Sarcomas of the Larynx: A Single Institutional Experience with Ten Cases

doi: 10.1007/s12105-019-01106-1

Figure Lengend Snippet: Immunohistochemistry antibodies used in this series

Article Snippet: Antibody clones, dilutions, and sources are reported in Table . table ft1 table-wrap mode="anchored" t5 Table 1 caption a7 Antigen Clone Dilution Source CK AE1/AE3 1:100 Dako LMWK Cam5.2 1:50 Becton–Dickinson CEA CEA31 1:400 Cell Marque CK5 EP1601Y 1:50 Cell Marque EMA E29 1:1000 Dako ERG EPR3864 1:100 Abcam p40 BC28 1:200 BioCare Medical p63 BC4A4 1:125 BioCare Medical SOX10 BC34 1:50 BioCare Medical Desmin D33 1:800 Dako Myogenin F5D 1:25 Cell Marque MyoD1 EP212 1:20 Cell Marque CD21 1F8 1:20 Dako CD35 EP197 1:400 Cell Marque ALK ALK-1 1:20 Cell Marque SATB2 CL0276 1:100 Sigma-Aldrich CD34 QBEnd 10 1:200 Dako SMA 1A4 1:200 Cell Marque STAT6 YE361 1:400 Abcam HHV-8 13B10 1:200 Cell Marque Open in a separate window CK indicates cytokeratin; LMCK low molecular weight keratin; EMA epithelial membrane antigen Immunohistochemistry antibodies used in this series Fluorescence in situ hybridization (FISH) Fluorescence in situ hybridization (FISH) for MDM2 amplification was performed according to a clinically validated laboratory protocol using the SpectrumOrange Vysis LSI (Abbott) MDM2 FISH probe.

Techniques: Immunohistochemistry